Literature DB >> 26648832

Clinical and Molecular Characterization of Osteogenesis Imperfecta Type V.

Evelise Brizola1, Eduardo P Mattos2, Jessica Ferrari3, Patricia O A Freire4, Raquel Germer5, Juan C Llerena5, Têmis M Félix6.   

Abstract

Osteogenesis imperfecta type V (OI-V) has a wide clinical variability, with distinct clinical/radiological features, such as calcification of the interosseous membrane (CIM) between the radius-ulna and/or tibia-fibula, hyperplastic callus (HPC) formation, dislocation of the radial head (DRH), and absence of dentinogenesis imperfecta (DI). Recently, a single heterozygous mutation (c.-14C>T) in the 5'UTR of the IFITM5 gene was identified to be causative for OI-V. Here, we describe 7 individuals from 5 unrelated families that carry the c.-14C>T IFITM5 mutation. The clinical findings in these cases are: absence of DI in all patients, presence of blue sclera in 2 cases, and 4 patients with DRH. Radiographic findings revealed HPC in 3 cases. All patients presented CIM between the radius and ulna, while 4 patients presented additional CIM between the tibia and fibula. Spinal fractures by vertebral compression were observed in all individuals. The proportion of cases identified with this mutation represents 4% of OI cases at our institution. The clinical identification of OI-V is crucial, as this mutation has an autosomal dominant inheritance with variable expressivity.

Entities:  

Keywords:  Autosomal dominant inheritance; IFITM5; Osteogenesis imperfecta

Year:  2015        PMID: 26648832      PMCID: PMC4662268          DOI: 10.1159/000439506

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  26 in total

1.  A recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V.

Authors:  Masaki Takagi; Shuhei Sato; Keiichi Hara; Chihiro Tani; Osamu Miyazaki; Gen Nishimura; Tomonobu Hasegawa
Journal:  Am J Med Genet A       Date:  2013-06-27       Impact factor: 2.802

Review 2.  Classification of Osteogenesis Imperfecta revisited.

Authors:  F S Van Dijk; G Pals; R R Van Rijn; P G J Nikkels; J M Cobben
Journal:  Eur J Med Genet       Date:  2009-10-28       Impact factor: 2.708

3.  A transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutation.

Authors:  Caressa D Lietman; Ronit Marom; Elda Munivez; Terry K Bertin; Ming-Ming Jiang; Yuqing Chen; Brian Dawson; Mary Ann Weis; David Eyre; Brendan Lee
Journal:  J Bone Miner Res       Date:  2015-03       Impact factor: 6.741

4.  Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression.

Authors:  Adi Reich; Alison S Bae; Aileen M Barnes; Wayne A Cabral; Aleksander Hinek; Jennifer Stimec; Suvimol C Hill; David Chitayat; Joan C Marini
Journal:  J Clin Endocrinol Metab       Date:  2014-11-11       Impact factor: 5.958

5.  Genotype-phenotype study in type V osteogenesis imperfecta.

Authors:  Meena Balasubramanian; Michael J Parker; Ann Dalton; Cecilia Giunta; Uschi Lindert; Luiz C Peres; Bart E Wagner; Paul Arundel; Amaka Offiah; Nicholas J Bishop
Journal:  Clin Dysmorphol       Date:  2013-07       Impact factor: 0.816

6.  A nonclassical IFITM5 mutation located in the coding region causes severe osteogenesis imperfecta with prenatal onset.

Authors:  Heike Hoyer-Kuhn; Oliver Semler; Lutz Garbes; Katharina Zimmermann; Jutta Becker; Bernd Wollnik; Eckhard Schoenau; Christian Netzer
Journal:  J Bone Miner Res       Date:  2014-06       Impact factor: 6.741

7.  Osteogenesis imperfecta without features of type V caused by a mutation in the IFITM5 gene.

Authors:  Monica Grover; Philippe M Campeau; Caressa Dee Lietman; James T Lu; Richard A Gibbs; Alan E Schlesinger; Brendan H Lee
Journal:  J Bone Miner Res       Date:  2013-11       Impact factor: 6.741

Review 8.  Nosology and classification of genetic skeletal disorders: 2010 revision.

Authors:  Matthew L Warman; Valerie Cormier-Daire; Christine Hall; Deborah Krakow; Ralph Lachman; Martine LeMerrer; Geert Mortier; Stefan Mundlos; Gen Nishimura; David L Rimoin; Stephen Robertson; Ravi Savarirayan; David Sillence; Juergen Spranger; Sheila Unger; Bernhard Zabel; Andrea Superti-Furga
Journal:  Am J Med Genet A       Date:  2011-03-15       Impact factor: 2.802

9.  A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus.

Authors:  Oliver Semler; Lutz Garbes; Katharina Keupp; Daniel Swan; Katharina Zimmermann; Jutta Becker; Sandra Iden; Brunhilde Wirth; Peer Eysel; Friederike Koerber; Eckhard Schoenau; Stefan K Bohlander; Bernd Wollnik; Christian Netzer
Journal:  Am J Hum Genet       Date:  2012-08-02       Impact factor: 11.043

10.  Phenotype and genotype analysis of Chinese patients with osteogenesis imperfecta type V.

Authors:  Zeng Zhang; Mei Li; Jin-Wei He; Wen-Zhen Fu; Chang-Qing Zhang; Zhen-Lin Zhang
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

View more
  7 in total

1.  Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation.

Authors:  Stéphane Blouin; Nadja Fratzl-Zelman; Francis H Glorieux; Paul Roschger; Klaus Klaushofer; Joan C Marini; Frank Rauch
Journal:  J Bone Miner Res       Date:  2017-06-26       Impact factor: 6.741

2.  Specific Characteristic of Hyperplastic Callus in a Larger Cohort of Osteogenesis Imperfecta Type V.

Authors:  Wen-Bin Zheng; Jing Hu; Jia Zhang; Zheng Yang; Ou Wang; Yan Jiang; Wei-Bo Xia; Xiao-Ping Xing; Wei Yu; Mei Li
Journal:  Calcif Tissue Int       Date:  2022-01-06       Impact factor: 4.333

3.  Oro-dental and cranio-facial characteristics of osteogenesis imperfecta type V.

Authors:  Jean-Marc Retrouvey; Doaa Taqi; Faleh Tamimi; Didem Dagdeviren; Francis H Glorieux; Brendan Lee; Renna Hazboun; Deborah Krakow; V Reid Sutton
Journal:  Eur J Med Genet       Date:  2018-12-26       Impact factor: 2.708

4.  Ocular characteristics and complications in patients with osteogenesis imperfecta: a systematic review.

Authors:  Sanne Treurniet; Pia Burger; Ebba A E Ghyczy; Frank D Verbraak; Katie R Curro-Tafili; Dimitra Micha; Nathalie Bravenboer; Stuart H Ralston; Ralph de Vries; Annette C Moll; Elisabeth Marelise W Eekhoff
Journal:  Acta Ophthalmol       Date:  2021-05-19       Impact factor: 3.988

5.  Cyclic pamidronate treatment for osteogenesis imperfecta: Report from a Brazilian reference center.

Authors:  Bruna Pinheiro; Marina B Zambrano; Ana Paula Vanz; Evelise Brizola; Liliane Todeschini de Souza; Têmis Maria Félix
Journal:  Genet Mol Biol       Date:  2019-04-25       Impact factor: 1.771

6.  Late onset hyperplastic callus formation in osteogenesis imperfecta type V simulating osteosarcoma-A case report.

Authors:  Hans Christoph Vonderlind; Matthias Jessel; Alexander Knobel; Ingke Juergensen; Johannes Struewer
Journal:  Int J Surg Case Rep       Date:  2020-03-28

7.  Case Report: Hyperplastic Callus of the Femur Mimicking Osteosarcoma in Osteogenesis Imperfecta Type V.

Authors:  Ying Deng; Yanan Huo; Jinfeng Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-15       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.